CTLA4 and neoplasm: Whereas CTLA-4 blockade stimulates the accumulation of 4PD-1hi cells in the tumor and periphery, PD-1 blockade opposes 4PD-1hi activity even in combination with anti-CTLA-4, thereby promoting a stronger antitumor immune response.2